BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

913 related articles for article (PubMed ID: 22447120)

  • 1. Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ.
    Hucke S; Floßdorf J; Grützke B; Dunay IR; Frenzel K; Jungverdorben J; Linnartz B; Mack M; Peitz M; Brüstle O; Kurts C; Klockgether T; Neumann H; Prinz M; Wiendl H; Knolle P; Klotz L
    Brain; 2012 May; 135(Pt 5):1586-605. PubMed ID: 22447120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis.
    Feinstein DL; Galea E; Gavrilyuk V; Brosnan CF; Whitacre CC; Dumitrescu-Ozimek L; Landreth GE; Pershadsingh HA; Weinberg G; Heneka MT
    Ann Neurol; 2002 Jun; 51(6):694-702. PubMed ID: 12112074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of inhibitory central nervous system-derived and stimulatory blood-derived dendritic cells suggests a dual role for granulocyte-macrophage colony-stimulating factor in central nervous system inflammation.
    Hesske L; Vincenzetti C; Heikenwalder M; Prinz M; Reith W; Fontana A; Suter T
    Brain; 2010 Jun; 133(Pt 6):1637-54. PubMed ID: 20424288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglial cell activation and proliferation precedes the onset of CNS autoimmunity.
    Ponomarev ED; Shriver LP; Maresz K; Dittel BN
    J Neurosci Res; 2005 Aug; 81(3):374-89. PubMed ID: 15959904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system.
    Mildner A; Mack M; Schmidt H; Brück W; Djukic M; Zabel MD; Hille A; Priller J; Prinz M
    Brain; 2009 Sep; 132(Pt 9):2487-500. PubMed ID: 19531531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
    Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
    Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-kappaB.
    Taoufik E; Tseveleki V; Chu SY; Tselios T; Karin M; Lassmann H; Szymkowski DE; Probert L
    Brain; 2011 Sep; 134(Pt 9):2722-35. PubMed ID: 21908876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC; Lalor SJ; Lynch MA; Mills KH
    Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gp130-dependent astrocytic survival is critical for the control of autoimmune central nervous system inflammation.
    Haroon F; Drögemüller K; Händel U; Brunn A; Reinhold D; Nishanth G; Mueller W; Trautwein C; Ernst M; Deckert M; Schlüter D
    J Immunol; 2011 Jun; 186(11):6521-31. PubMed ID: 21515788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis.
    Takahashi K; Prinz M; Stagi M; Chechneva O; Neumann H
    PLoS Med; 2007 Apr; 4(4):e124. PubMed ID: 17425404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy.
    Blyszczuk P; Kania G; Dieterle T; Marty RR; Valaperti A; Berthonneche C; Pedrazzini T; Berger CT; Dirnhofer S; Matter CM; Penninger JM; Lüscher TF; Eriksson U
    Circ Res; 2009 Oct; 105(9):912-20. PubMed ID: 19762681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis.
    Linker RA; Lee DH; Demir S; Wiese S; Kruse N; Siglienti I; Gerhardt E; Neumann H; Sendtner M; Lühder F; Gold R
    Brain; 2010 Aug; 133(Pt 8):2248-63. PubMed ID: 20826430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system.
    Prinz M; Schmidt H; Mildner A; Knobeloch KP; Hanisch UK; Raasch J; Merkler D; Detje C; Gutcher I; Mages J; Lang R; Martin R; Gold R; Becher B; Brück W; Kalinke U
    Immunity; 2008 May; 28(5):675-86. PubMed ID: 18424188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor gamma is mediated by up-regulation of B7H1.
    Klotz L; Hucke S; Thimm D; Classen S; Gaarz A; Schultze J; Edenhofer F; Kurts C; Klockgether T; Limmer A; Knolle P; Burgdorf S
    J Immunol; 2009 Jul; 183(1):129-36. PubMed ID: 19535643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice.
    Tran EH; Hoekstra K; van Rooijen N; Dijkstra CD; Owens T
    J Immunol; 1998 Oct; 161(7):3767-75. PubMed ID: 9759903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Ninjurin-1 in the migration of myeloid cells to central nervous system inflammatory lesions.
    Ifergan I; Kebir H; Terouz S; Alvarez JI; Lécuyer MA; Gendron S; Bourbonnière L; Dunay IR; Bouthillier A; Moumdjian R; Fontana A; Haqqani A; Klopstein A; Prinz M; López-Vales R; Birchler T; Prat A
    Ann Neurol; 2011 Nov; 70(5):751-63. PubMed ID: 22162058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naive CD8 T-cells initiate spontaneous autoimmunity to a sequestered model antigen of the central nervous system.
    Na SY; Cao Y; Toben C; Nitschke L; Stadelmann C; Gold R; Schimpl A; Hünig T
    Brain; 2008 Sep; 131(Pt 9):2353-65. PubMed ID: 18669487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the HGF receptor c-met by macrophages in experimental autoimmune encephalomyelitis.
    Moransard M; Sawitzky M; Fontana A; Suter T
    Glia; 2010 Apr; 58(5):559-71. PubMed ID: 19941340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of CCR2 expressing lymphomyeloid cells in experimental autoimmune encephalomyelitis by a GM-CSF-MCP1 fusokine.
    Rafei M; Campeau PM; Wu JH; Birman E; Forner K; Boivin MN; Galipeau J
    J Immunol; 2009 Mar; 182(5):2620-7. PubMed ID: 19234156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic expression of CCL2 in the central nervous system prevents experimental autoimmune encephalomyelitis.
    Elhofy A; Wang J; Tani M; Fife BT; Kennedy KJ; Bennett J; Huang D; Ransohoff RM; Karpus WJ
    J Leukoc Biol; 2005 Feb; 77(2):229-37. PubMed ID: 15539456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.